Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:10 PM UTC
| NCT Number | NCT06656390 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 202 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Shanghai Allink Biotherapeutics Co., Ltd. |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 13, 2026: Clinical trial NCT06656390 is currently recruiting participants. This clinical trial study for advanced cancer is actively seeking new participants at 4 locations across the United States. The study is sponsored by Shanghai Allink Biotherapeutics Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06656390 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06656390 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.